Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum CalciMedica Inc CALC

CalciMedica, Inc. is a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses. The Company's technology targets the inhibition of CRAC channels to modulate the immune response and protect against tissue cell injury. Its lead product candidate is Auxora... see more

NDAQ:CALC - Post Discussion

CalciMedica Inc > Graycliff Exploration Fall Mining Showcase: Watch the Replay
View:
Post by yukon_gold on Nov 17, 2022 9:11pm

Graycliff Exploration Fall Mining Showcase: Watch the Replay

Graycliff Exploration at the RedCloud Fall Mining Showcase 2022: Watch the Replays

Thank you to everybody who attended Graycliff's presentation at the RedCloud Fall Mining Showcase last week. In case you missed it, watch our presentation replay where James Macintosh, President, CEO and Director, provided a full company overview, exploration updates, and a rundown of upcoming milestones.

 

Click on the video below to watch.

James Macintosh also joined RedCloud's Mark Bunting for a chat about the Company and why it should be on the investors' radars. Click on the image below to hear exclusive project updates.

Visit our website

 

For more information, please contact investor relations at 1-647-249-9298, or email investors@graycliffexploration.com.


Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities